GEMINI BIOPRODUCTS, INC. – Trademark Portfolio
Entity Type: 03
GEMINI BIOPRODUCTS, INC. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 13 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include GEMINI, STASIS, GEMCELL, BENCHMARK, and NEUROPLEX. The owner is based in West Sacramento, CA.
920 Stillwater Road, Suite 130
West Sacramento, CA 95605
Showing of trademarks Trademarks
Trademark Classifications
GEMINI BIOPRODUCTS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does GEMINI BIOPRODUCTS, INC. have?
GEMINI BIOPRODUCTS, INC. has 15 U.S. trademarks filed with the USPTO. Of these, 9 registered, 1 abandoned, 5 cancelled.
What trademark classes does GEMINI BIOPRODUCTS, INC. file in?
GEMINI BIOPRODUCTS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are GEMINI BIOPRODUCTS, INC.'s most well-known trademarks?
GEMINI BIOPRODUCTS, INC.'s registered trademark portfolio includes well-known marks such as GEMINI, STASIS, GEMCELL, BENCHMARK, and NEUROPLEX. These are among 9 currently registered trademarks in the portfolio.
What is GEMINI BIOPRODUCTS, INC.'s trademark registration success rate?
GEMINI BIOPRODUCTS, INC. has a 60% trademark registration rate, with 9 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.